null

SMILES: Cc1ccc(Oc2ccc(cc2)N(C[C@H](NC2CCCC2)C(=O)NO)S(C)(=O)=O)cc1

InChI Key: InChIKey=AIVGSEYFSRMFJB-NRFANRHFSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50230524   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Matrix metalloproteinase-9 (Homo sapiens (Human))	BDBM50230524 ((S)-2-(cyclopentylamino)-N-hydroxy-3-(N-(4-(p-toly...) Show SMILES Cc1ccc(Oc2ccc(cc2)N(C[C@H](NC2CCCC2)C(=O)NO)S(C)(=O)=O)cc1 Show InChI InChI=1S/C22H29N3O5S/c1-16-7-11-19(12-8-16)30-20-13-9-18(10-14-20)25(31(2,28)29)15-21(22(26)24-27)23-17-5-3-4-6-17/h7-14,17,21,23,27H,3-6,15H2,1-2H3,(H,24,26)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	1.70	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of MMP9				Bioorg Med Chem Lett 18: 1140-5 (2008) Article DOI: 10.1016/j.bmcl.2007.11.129 BindingDB Entry DOI: 10.7270/Q2BP02JM
					More data for this Ligand-Target Pair
72 kDa type IV collagenase (Homo sapiens (Human))	BDBM50230524 ((S)-2-(cyclopentylamino)-N-hydroxy-3-(N-(4-(p-toly...) Show SMILES Cc1ccc(Oc2ccc(cc2)N(C[C@H](NC2CCCC2)C(=O)NO)S(C)(=O)=O)cc1 Show InChI InChI=1S/C22H29N3O5S/c1-16-7-11-19(12-8-16)30-20-13-9-18(10-14-20)25(31(2,28)29)15-21(22(26)24-27)23-17-5-3-4-6-17/h7-14,17,21,23,27H,3-6,15H2,1-2H3,(H,24,26)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of MMP2				Bioorg Med Chem Lett 18: 1140-5 (2008) Article DOI: 10.1016/j.bmcl.2007.11.129 BindingDB Entry DOI: 10.7270/Q2BP02JM
					More data for this Ligand-Target Pair
Interstitial collagenase (Homo sapiens (Human))	BDBM50230524 ((S)-2-(cyclopentylamino)-N-hydroxy-3-(N-(4-(p-toly...) Show SMILES Cc1ccc(Oc2ccc(cc2)N(C[C@H](NC2CCCC2)C(=O)NO)S(C)(=O)=O)cc1 Show InChI InChI=1S/C22H29N3O5S/c1-16-7-11-19(12-8-16)30-20-13-9-18(10-14-20)25(31(2,28)29)15-21(22(26)24-27)23-17-5-3-4-6-17/h7-14,17,21,23,27H,3-6,15H2,1-2H3,(H,24,26)/t21-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of MMP1				Bioorg Med Chem Lett 18: 1140-5 (2008) Article DOI: 10.1016/j.bmcl.2007.11.129 BindingDB Entry DOI: 10.7270/Q2BP02JM
					More data for this Ligand-Target Pair